Status:
UNKNOWN
Novel Nanofat Regenerative Surgical Technique for Peyronies' Disease Treatment
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Peyronie Disease
Eligibility:
MALE
18-80 years
Phase:
NA
Brief Summary
Peyronies' disease (PD) is an acquired connective tissue disorder characterized with the growth of fibrous and/or calcified plaques in the tunica albuginea of the penis. The pathogenesis is still unc...
Detailed Description
The etiology of PD remains uncertain, but is well accepted that there is a chronic inflammation of tunica albuginea and this reflect perturbations in normal wound healing and aberrant deposition of ex...
Eligibility Criteria
Inclusion
- Presence of albuginea penile plaque due to Peyronies' disease associated with penile curvature and pain. Normal erectile function. Sexual activity.
Exclusion
- Erectile dysfunction, no sexual activity.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT05316714
Start Date
January 1 2021
End Date
August 15 2022
Last Update
July 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antonio Luigi Pastore
Latina, Italy, 04100